Page last updated: 2024-08-17

quinoxalines and Mood Disorders

quinoxalines has been researched along with Mood Disorders in 5 studies

Research

Authors	Studies
Bundo, M; Iwamoto, K; Kato, T; Kubota-Sakashita, M	1
Catz, SL; Deprey, M; Jack, L; Javitz, H; McAfee, TA; McClure, JB; Richards, J; Swan, GE; Zbikowski, SM	1
Mambourg, SE; Nelson, LA; Purvis, TL	1
Blendy, JA; Castellano, LM; Turner, JR	1
Chen, MC; Jeang, SY; Liu, ME; Peng, SL; Tsai, SJ; Tsai, YL; Wu, SL; Yang, ST	1

1 review(s) available for quinoxalines and Mood Disorders

Article	Year
Varenicline use in patients with mental illness: an update of the evidence. Expert opinion on drug safety, 2010, Volume: 9, Issue:3 Topics: Benzazepines; Evidence-Based Medicine; Humans; Limbic System; Mental Disorders; Mood Disorders; Patient Education as Topic; Quinoxalines; Smoking; Smoking Cessation; Suicide; Treatment Outcome; Varenicline	2010

1 trial(s) available for quinoxalines and Mood Disorders

Article	Year
Mood, side-effects and smoking outcomes among persons with and without probable lifetime depression taking varenicline. Journal of general internal medicine, 2009, Volume: 24, Issue:5 Topics: Adult; Affect; Benzazepines; Depressive Disorder; Female; Follow-Up Studies; Humans; Male; Middle Aged; Mood Disorders; Quinoxalines; Smoking; Smoking Cessation; Varenicline	2009

3 other study(ies) available for quinoxalines and Mood Disorders

Article	Year
A role of ADAR2 and RNA editing of glutamate receptors in mood disorders and schizophrenia. Molecular brain, 2014, Jan-21, Volume: 7 Topics: Adenosine Deaminase; Animals; Behavior, Animal; Brain; Humans; Mice; Mice, Inbred C57BL; Mice, Knockout; Mood Disorders; Motor Activity; Postmortem Changes; Quinoxalines; Receptors, AMPA; Receptors, Glutamate; RNA Editing; RNA-Binding Proteins; Schizophrenia	2014
Nicotinic partial agonists varenicline and sazetidine-A have differential effects on affective behavior. The Journal of pharmacology and experimental therapeutics, 2010, Volume: 334, Issue:2 Topics: Animals; Anxiety; Azetidines; Behavior, Animal; Benzazepines; Chimera; Depression; Drug Partial Agonism; Male; Mice; Mood Disorders; Nicotine; Nicotinic Agonists; Pyridines; Quinoxalines; Varenicline	2010
Varenicline prevents affective and cognitive exacerbation during smoking abstinence in male patients with schizophrenia. Psychiatry research, 2011, Nov-30, Volume: 190, Issue:1 Topics: Adult; Analysis of Variance; Benzazepines; Cognition; Humans; Male; Middle Aged; Mood Disorders; Neuropsychological Tests; Nicotinic Agonists; Psychiatric Status Rating Scales; Quinoxalines; Regression Analysis; Schizophrenia; Schizophrenic Psychology; Smoking; Smoking Cessation; Time Factors; Treatment Outcome; Varenicline	2011